PEARW - Pear Therapeutics Inc. (PEAR) CEO Corey McCann on Q4 2021 Results - Earnings Call Transcript
Pear Therapeutics, Inc. (PEAR) Q4 2021 Earnings Conference Call March 28, 2022 16:30 ET Corporate Participants Meera Murphy - Senior Director of Corporate Communications Corey McCann - President & CEO Chris Guiffre - Chief Financial Officer and Chief Operating Officer Erin Brenner - Chief Product Development Officer Yuri Maricich - Chief Medical Officer Ronan O'Brien - General Counsel and Chief Compliance Officer Julia Strandberg - Chief Commercial Officer Conference Call Participants Michael Cherny - Bank of America Judah Frommer - Credit Suisse Eric Percher - Nephron Research Keay Nakae - Chardan Charles Rhyee - Cowen Marie Thibault - BTIG Neena Bitritto-Garg - Citi Presentation Operator Good afternoon, everyone. Welcome to the Pear Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call. My name is Gigi and I will be your operator for today. Please note that all lines have been placed on mute to prevent any background noise.
For further details see:
Pear Therapeutics, Inc. (PEAR) CEO Corey McCann on Q4 2021 Results - Earnings Call Transcript